Cidara Therapeutics: Still Big Catalysts Ahead Following Impressive Ph2b Readout

Core Insights - The article discusses the investment potential of CDTX, highlighting a beneficial long position in its shares [1]. Group 1 - The analyst expresses a personal opinion on CDTX, indicating a positive outlook based on their own analysis [1]. - There is no compensation received for the article, emphasizing the independence of the analysis [1]. - The article does not provide specific investment recommendations, focusing instead on the author's views [2].